Vaccine Trial Challenges

The emergency use authorization for Pfizer's vaccine may complicate ongoing clinical trials for other candidates, as participants might opt for available vaccines instead of remaining in placebo groups. To ensure safety, multiple federal programs will monitor potential rare side effects as millions receive vaccines, addressing concerns not captured in smaller clinical trials.